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ciation for Thoracic Surgerydoi:10.1016/j.jtcvs.2004.12.037Objective: Even under optimal circumstances, total cavopulmonary connection is
associated with a continuous late risk of death. Hemodynamics are distinctly
abnormal, with increased systemic venous pressures and frequent low cardiac
output. Our study uses a sheep model of total cavopulmonary connection to test the
response to axial flow pump (Thoratec HeartMate II; Thoratec Corporation (Pleas-
anton, Calif) support of total cavopulmonary connection, which might be suitable to
treat patients with failing Fontan circulation.
Methods: Eight sheep (42-48 kg) were studied. After pilot studies in 3 animals, 5
underwent both pump-supported and nonsupported total cavopulmonary connection
in alternating sequence for up to 2 hours. This was achieved with a 12-mm
polytetrafluoroethylene graft from the (distally ligated) superior vena cava to the
main pulmonary artery and a cannula placed in the inferior vena cava with an
attached 16-mm Dacron graft to the main pulmonary artery. Pressures (arterial,
inferior vena cava, left atrium, and pulmonary artery) and flows (ascending aorta
and inferior vena cava) were recorded over 1 hour both with unsupported total
cavopulmonary connection and after placing an axial flow pump (Thoratec Heart-
Mate II) between the inferior vena caval inflow cannula and the main pulmonary
artery.
Results: Under nonsupported total cavopulmonary connection circulation, inferior
vena caval and aortic blood flow decreased by nearly 50%. Inferior vena caval
pressure nearly doubled, whereas arterial pressure decreased by one third. Pulmo-
nary artery pressure became nonpulsatile; however, mean pulmonary artery pressure
and left atrial pressure did not change significantly. With pump-supported Fontan
circulation, cardiac output, inferior vena caval flow, and arterial pressure returned to
baseline. Inferior vena caval pressure decreased to below baseline levels. Mean
pulmonary artery pressure and left atrial pressure again remained unchanged.
Conclusions: Axial flow pump support from the inferior vena cava to the pulmonary
artery can prevent the substantial decrease of aortic flow and pressure associated
with total cavopulmonary connection and can reverse its poor hemodynamics. This
is a simple model that can be used to further evaluate the potential of mechanical
support as a treatment option in failing Fontan circulation.
Total cavopulmonary connection (TCPC; Fontan circulation) produces a uniquephysiology in which pulmonary blood flow is driven primarily by the residualforce of the systemic ventricle. It is therefore usually accompanied by substantial
increases of systemic venous pressure. Even though most patients’ clinical state is good,
objectively measured hemodynamics and exercise tolerance are frequently abnormal.
Furthermore, there appears to be a continuous late risk of death, even increasing after 6
years postoperatively while functional status decreases.1
Up to 40% of patients undergoing TCPC experience heart failure.2 Late abnor-
malities of liver function are frequent.3 Protein-losing enteropathy is diagnosed in
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CSPup to 15% of patients and has a 5-year mortality rate of
50%.4 Medical treatment options are limited. In rare cases
of Fontan pathway obstruction, revision is indicated. Car-
diac transplantation is the only remaining option for patients
refractory to all other treatments. This option is, however,
associated with increased risk because of the poor condition
of patients with failing Fontan circulation.5
Mechanical circulatory support for left ventricular failure
with pulsatile and, more recently, axial flow pumps is now
state of the art clinically. However there is little experience
with axial flow pumps in low-pressure circuits, such as support
of the right ventricle or even a TCPC circulation. Pump sup-
port could conceivably reverse poor hemodynamics and sec-
ondary organ failure in patients with failing Fontan circulation,
could make these patients more successful transplant candi-
dates, or could be used as destination therapy. In this study we
compared the acute physiologic response to passive TCPC
with that of mechanically supported TCPC by using an axial
flow blood pump in a sheep model. Our objective was to define
the initial adaptive response of the circulation to passive TCPC
and determine the feasibility of mechanical support to restore
hemodynamics.
Figure 1. Photograph of TCPC without pump assist in a sheep:
surgeon’s view showing the SVC-PA and PA-IVC conduits in situ.
Portions of the right (RV) and left ventricular (LV) free walls are
shown.352 The Journal of Thoracic and Cardiovascular Surgery ● AuguMethods
Animal Care
We used a total of 8 sheep (Western breed, 42-48 kg) in this study;
3 animals were used for preliminary studies. All animals received
humane care in compliance with the “Guide for Care and Use of
Laboratory Animals.” All conditions for animal surgery and care
were approved by the Stanford University Institutional Animal
Care and Use Committee. Animals were premedicated with ket-
amine and diazepam (Valium; 10 and 0.5 mg/kg administered
intravenously, respectively), intubated, ventilated to maintain a
blood PCO2 value of between 35 and 45 mm Hg, and maintained
under 1% to 2% isoflurane anesthesia. At the end of the study, they
were killed with pentobarbital (150 mg/kg).
Surgical Preparation
We performed a midline sternotomy; inserted pressure catheters
into the left atrium, right atrium (RA), inferior vena cava (IVC),
and main pulmonary artery (PA); and placed perivascular ultra-
sonic flow probes (Transonics Systems, Inc, Ithaca, NY) around
the IVC distal to the anastomosis and on the ascending aorta. All
pressures and flows were continuously monitored and recorded.
We mobilized the IVC, superior vena cava (SVC), and main
PA and ligated the azygous vein. After heparinization with 300
U/kg, we fashioned a bidirectional Glenn connection by anasto-
mosing a 12-mm polytetrafluoroethylene (PTFE; Gore-Tex vascu-
lar graft, registered trademark of W. L. Gore & Associates, Inc,
Newark, Del) vascular graft from the SVC to the main PA in
side-to-side fashion and ligating the SVC-RA junction. For non-
supported TCPC, we connected the IVC and main PA with a
16-mm PTFE graft and ligated the IVC-RA connection (Figure 1).
To test pump-supported TCPC, we placed a right-angled Thoratec
inflow cannula connected to an axial flow pump (Thoratec Heart-
Mate II; Thoratec Corporation, Pleasanton, Calif) into the IVC. Its
outflow end was connected to a 16-mm Dacron graft anastomosed
to the proximal main PA. We then again ligated the IVC-RA
connection (Figure 2). These graft diameters were chosen to match
the sheep’s SVC and IVC diameters. The chest was approximated
with clamps. All animals were studied with and without mechan-
ical support in random order. The PTFE graft was clamped before
insertion of the axial flow pump, or vice versa, the pump was
removed before opening the PTFE graft. Therefore, all animals
served as their own controls. Hemodynamic variables were re-
Figure 2. Photograph of TCPC with the HeartMate II
ventricular assist device in a sheep: surgeon’s view
of pump and conduits in situ. Arrow indicates direc-
tion of blood flow through the pump. RV, Right ven-
tricular free wall.st 2005
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Pcorded over a period of 1 to 2 hours each before intervention and
with unsupported and supported TCPC, respectively.
Pump Regulation
In all animals the pump was set at a speed of 6000 rpm for the
duration of pump support. In 3 animals pump speed was varied for
a short time to observe changes in hemodynamics and to monitor
for IVC collapse. The pump dynamics data will be presented
elsewhere.
Metabolic Analyses
Hourly arterial blood gas measurements were obtained to monitor
ventilation and base excess. In addition, oxygen saturations in PA
and IVC blood, serum lactate levels, and aspartate aminotransfer-
ase and alanine aminotransferase concentrations were measured
before and during supported and nonsupported TCPC after 30-
minute equilibration periods.
Statistical Analysis
Hemodynamic values were analyzed by means of analysis of
variance with paired comparison between baseline, unassisted, and
ventricular assist device–assisted states. The analysis was con-
ducted with the JMP software package (SAS Institute, Inc, Cary,
NC). A significance level of .05 was the minimum criterion for
acceptance of differences between groups. All data values are
expressed as means  standard error unless otherwise stated.
Results
Hemodynamics at Baseline and After TCPC
All animals survived the study. Measured hemodynamic
variables are summarized in Table 1. Compared with biven-
tricular circulation, aortic and IVC flow decreased signifi-
cantly by 56%  4% and 46%  4%, respectively. Arterial
pressure also decreased significantly with TCPC, whereas
left atrial pressure did not change substantially. TCPC did
not significantly affect pulmonary arterial pressure. Direct
connection with the PA resulted in an IVC pressure increase
from baseline (by 130%  30%) to match PA pressure.
Hemodynamics With Ventricular Assist
Device–Supported TCPC
Axial pump support from the IVC to the PA restored aortic
and IVC flows to pre-TCPC values. Arterial pressure also
TABLE 1. Hemodynamic values For different circulatory co
Circulation Baseline
IVC flow, L/min 2.02 0.21 (5)
Aortic flow (CO), L/min 3.89 0.13 (5)
Arterial pressure, mm Hg 68.9 3.3 (5)
LA pressure, mm Hg 6.4 0.75 (5)
IVC pressure, mm Hg 5.00 0.84 (5)
PA pressure, mm Hg 11.8 0.80 (5)
TCPC, Total cavopulmonary connection; IVC, inferior vena cava; CO, cardia
 standard error of the mean (n). †P  .05 versus baseline. ‡P  .05 verecovered to baseline. IVC pressure was decreased to
The Journal of Thoraciaround 0 mm Hg, which was significantly less than baseline
values. Left atrial pressure again remained unchanged,
whereas PA pressure was mildly increased with pump sup-
port (Table 1).
Venous Collapse
At a pump speed of 6000 rpm, the IVC was subject to
intermittent collapse and oscillation in all animals. How-
ever, this did not appear to affect overall IVC flows. In
preliminary studies we verified that further increasing pump
speed induced more prolonged IVC collapse, leading to
brief and intermittent decreases in flow.
Metabolic Changes
During the relatively brief course of the experiment, we did
not observe significant metabolic or lactic acidosis or in-
creases of aspartate aminotransferase or alanine aminotrans-
ferase concentrations. Mixed venous saturations were mea-
sured in 5 animals: the median was 87% at baseline, 61% at
the passive Fontan state, and 82% during Fontan circulation
with pump support. Because of the small number of obser-




We used a simple and reliable model for TCPC that has not
been used in sheep before. This model does not require
cardiopulmonary bypass (CPB), avoiding its associated po-
tential volume shifts, blood transfusions, and influences on
pulmonary vascular resistance and lung function. It appears
well suited to study hemodynamics in Fontan circulation.
Two groups have applied a similar model in dogs before:
Nawa and colleagues,6 who also avoided CPB, and Mace
and associates,7 who used CPB. Both were able to show that
dogs tolerate TCPC in the acute setting.
A limitation of this model is the incomplete bypass of the
right heart in that coronary sinus flow is still being pumped by
the right ventricle. However, this did not lead to any apprecia-
ble pulsatility of the PA pressure tracing in our study. It
appears that coronary sinus flow is not substantial enough to
urations*
TCPC TCPC with pump
0.88 0.10 (5)† 2.6 0.26 (4)‡
2.10 0.13 (5)† 4.18 0.36 (4)‡
42.4 42.8 (5)† 64.5 9.13 (4)‡
5.2 0.73 (5) 7.5 1.2 (4)
10.6 1.12 (5)† 0.25 0.48 (4)†‡
10.0 1.10 (5) 13.75 1.03 (4)
put; LA, left atrial; PA, pulmonary artery. *Values are presented as means
otal cavopulmonary connection.nfigaffect the hemodynamics of this experiment significantly.
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CSPHemodynamics in TCPC
In the previously reported studies, cardiac index was sub-
stantially reduced with TCPC; however, output could be
maintained by substantial volume loading.6,7 In our sheep
model we have seen an even greater decrease of cardiac
output and blood pressure with TCPC without volume load-
ing. As expected, IVC pressure was significantly increased
in TCPC. Additionally, we measured IVC flow, which was
significantly reduced along with cardiac output.
As in the previous studies in dogs, all animals survived in
the acute setting. Chronic studies (already underway) will
have to be performed to determine whether sheep can sur-
vive TCPC long term.
Pump Support of TCPC
Axial flow pump support from the IVC to the PA reversed
the negative hemodynamics of passive TCPC. Cardiac out-
put, IVC flow, and arterial pressure were similar to biven-
tricular circulation without volume administration, illustrat-
ing the potential feasibility of pump support of Fontan
circulation. IVC pressure in pump-supported TCPC is low,
potentially allowing for recovery from liver failure or protein-
losing enteropathy.
Rodefeld and coworkers8 were the first to apply pump
support of TCPC in an animal model, using 2 Hemopumps
in the SVC and IVC. They were able to show feasibility of
mechanical support; however, they failed to provide a con-
trol group for comparison of hemodynamics. This study
uses each animal as its own control, clearly proving the
improvement of hemodynamics of pump-supported versus
passive Fontan circulation.
IVC Collapse
The Thoratec HeartMate II is a powerful axial flow pump
designed for use in the systemic circulation of adults. We
would have considered using a smaller pump in this exper-
iment if it had been available to us. However, despite
negative IVC pressures, we did not encounter as many
problems with IVC collapse and associated reduction of
pump inflow as we anticipated. Even though we consis-
tently experienced oscillations of the IVC wall and moder-
ate IVC collapse, pump flow remained stable throughout at
the recommended minimum of 6000 rpm. Even with in-
creased revolutions per minute, there was only intermittent
and self-limiting inflow reduction.
Thrombosis
During the short duration of this study in heparinized animals,
we did not encounter any thromboembolic problems. This,
however, remains a concern, particularly when using a pump
designed for higher flows. The need for anticoagulation will
have to be evaluated in subsequent chronic studies.
354 The Journal of Thoracic and Cardiovascular Surgery ● AuguOther Limitations
Anesthetic drugs are known to adversely affect the hemody-
namics of TCPC. Therefore the concentration of inhaled an-
esthesia was kept constant during the periods of passive and
pump-supported TCPC, minimizing its influence on the data.
Positive pressure ventilation could also affect hemody-
namics unfavorably. However, in our experience chest ap-
proximation did not change pressures and flows signifi-
cantly. The data in these series of experiments did not
suggest major compression of the grafts by means of chest
approximation, although we have seen graft compression in
chronic preparations when the animal’s position was
changed.
The relatively large size of the Thoratec HeartMate II
pump could obviously be of concern in smaller animals and,
eventually, in small patients. It was not a limitation in this
study with large sheep.
Conclusions
Mechanical support of TCPC with an axial flow pump is
feasible in the acute experiment in sheep, leading to reversal
of the reduction of cardiac output, IVC flow, and blood
pressure that is associated with acute TCPC. This principle
could lead to further advanced approaches to improve pa-
tients with failing Fontan circulation, whose therapeutic
options are otherwise severely limited.
We thank Mario Trujillo for technical assistance with the
animals.
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